Free Newsletter
Interspecies stem cells one step closer in Korea
A team of Korean researchers has come close to creating interspecies stem cells by combining monkey cells with cow ova. The resulting blastocyst--a source of stem cells--did not thrive. But researchers say they feel confident that their approach will deliver batches of fresh cells. Culturing new stem cell lines from animal ova would advance research testing new therapies as well as offer an approach that could conceivably avert having to use cloned human embryonic stem cells in therapeutic research. It may also substitute one controversy in exchange for another, as the scientific community confronts a reaction against the development of animal chimeras.
- read the Korea Times report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: